CDKN2A and metabolic disease: Collectively, our findings unveil insights into the molecular mechanisms by which Cdkn2a regulates beige adipocyte maintenance via BECN1-mediated autophagy and provide a potential therapeutic strategy to lock into a stable beige identity and treat obesity and related metabolic diseases.